Valneva SE (VALN) Net Margin (2021 - 2026)

Valneva SE's (VALN) quarterly Net Margin came in at 77.65% in Q1 2026, down 6538.0% year-on-year from 1.21% in Q1 2025, and up 40.3% quarter-over-quarter from 130.08% in Q4 2025.

Valneva SE (VALN) Net Margin (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Net Margin across 6 years of filings, most recently posting 77.65% for Q1 2026.

  • Net Margin for Q1 2026 came in at 77.65%, down 6538.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 87.63% (down 5369.0% YoY), and the FY2025 annual result was 72.97%, down 8113.0% from the prior year.
  • Net Margin came in at 77.65% for Q1 2026 at Valneva SE, up from 130.08% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 212.16% in Q1 2024 to a low of 826.38% in Q2 2022.
  • The 5-year median for Net Margin is 52.34% (2023), against an average of 85.42%.
  • Peak annual rise in Net Margin reached 132534 bps in 2022, while the deepest fall reached 110567 bps in 2022.
  • Valneva SE's Net Margin stood at 139.56% in 2022, then surged by 62 bps to 52.34% in 2023, then rose by 21 bps to 41.11% in 2024, then tumbled by 216 bps to 130.08% in 2025, then soared by 40 bps to 77.65% in 2026.
  • The last three Net Margin figures came in at 77.65% (Q1 2026), 130.08% (Q4 2025), and 130.78% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 34.53%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -77.65%

Historic Data

Download Data
DateValue
Mar 31, 2026 -77.65%
Dec 31, 2025 -130.08%
Sep 30, 2025 -130.78%
Jun 30, 2025 -25.62%
Mar 31, 2025 -12.26%
Dec 31, 2024 -41.11%
Sep 30, 2024 -28.15%
Jun 30, 2024 -59.63%
Mar 31, 2024 212.16%
Dec 31, 2023 -52.34%
Sep 30, 2023 -60.92%
Jun 30, 2023 -48.96%
Mar 31, 2023 -51.63%
Dec 31, 2022 -139.56%
Sep 30, 2022 175.73%
Jun 30, 2022 -826.38%
Mar 31, 2022 -154.91%
Dec 31, 2021 966.11%
Sep 30, 2021 -1,149.61%
Jun 30, 2021 -362.09%